Remedent specializes in the research, development, and manufacturing of oral care and cosmetic dentistry products. The Company has developed a system for manufacturing and installing dental veneers which are branded as GlamSmile. GlamSmile veneers are attached to the front of the patient’s teeth using a single motion placement tray which replaces the traditional method of applying porcelain veneers, making the application less traumatic for the patient and much easier for the dentist. 

Type
Public
HQ
Gent, BE
Founded
1986
Size (employees)
16 (est)
Remedent was founded in 1986 and is headquartered in Gent, BE
Report incorrect company information

Remedent Office Locations

Remedent has an office in Gent
Gent, BE (HQ)
1 Zuiderlaan
Show all (1)
Report incorrect company information

Remedent Financials and Metrics

Remedent Financials

Remedent's revenue was reported to be $2.77 m in FY, 2016 which is a 23.4% decrease from the previous period.
USD

Revenue (Q2, 2018)

678.7 k

Gross profit (Q2, 2018)

481 k

Gross profit margin (Q2, 2018), %

70.9%

EBIT (Q2, 2018)

(46.2 k)

Market capitalization (31-Oct-2017)

5.6 m

Closing share price (31-Oct-2017)

0.3

Cash (30-Sep-2017)

88.8 k
Remedent's current market capitalization is $5.6 m.
Annual
USDFY, 2014FY, 2015FY, 2016

Revenue

2.6 m3.6 m2.8 m

Revenue growth, %

39%(23%)

Cost of goods sold

965 k1.3 m817.4 k

Gross profit

1.6 m2.3 m2 m
Quarterly
USDQ2, 2018

Revenue

678.7 k

Cost of goods sold

197.7 k

Gross profit

481 k

Gross profit Margin, %

71%
Annual
USDFY, 2014FY, 2015FY, 2016

Cash

775.3 k399.1 k94.4 k

Current Assets

3.4 m2.9 m2.9 m

PP&E

489.4 k435.3 k410.9 k

Total Assets

6.2 m5.5 m5.7 m
Quarterly
USDQ2, 2018

Cash

88.8 k

Inventories

122 k

Current Assets

1.4 m

PP&E

224.5 k
USDFY, 2014FY, 2015FY, 2016

Net Income

524.5 k

Depreciation and Amortization

240 k254.8 k158.5 k

Cash From Operating Activities

(103.9 k)300.6 k(203.1 k)

Cash From Investing Activities

(81.4 k)(240.5 k)(116.3 k)
USDY, 2017

Revenue/Employee

42.4 k

Financial Leverage

1.5 x
Show all financial metrics
Report incorrect company information